Frequency, predictors, and outcomes of urine drug testing among patients with advanced cancer on chronic opioid therapy at an outpatient supportive care clinic.
Joseph A ArthurTonya EdwardsZhanni LuSuresh ReddyDavid HuiJimin WuDiane LiuJanet L WilliamsEduardo BrueraPublished in: Cancer (2016)
UDTs were used infrequently among outpatients with advanced cancer who were receiving chronic opioid therapy. Younger age, positive CAGE questionnaire results, early stage cancer or no evidence of disease status, higher pain intensity, and lower fatigue scores were significant predictors of UDT ordering. More than 50% of UDT results were abnormal. More research is necessary to better characterize aberrant opioid use in patients with advanced cancer. Cancer 2016;122:3732-9. © 2016 American Cancer Society.
Keyphrases
- advanced cancer
- palliative care
- papillary thyroid
- chronic pain
- pain management
- early stage
- squamous cell
- healthcare
- lymph node metastasis
- primary care
- bone marrow
- childhood cancer
- adipose tissue
- spinal cord injury
- mesenchymal stem cells
- metabolic syndrome
- physical activity
- high intensity
- skeletal muscle
- quality improvement
- lymph node
- sentinel lymph node
- rectal cancer
- neoadjuvant chemotherapy